تأثير إدارة البيراسيتام على الوقاية من الشلل الدماغي في أجنة الفئران المولودة للفئران الحوامل عن طريق تحديد مستويات Bdnf في أنسجة المخ

Joshua AV. Cerebral Palsy: An Overview of Etiology, Types and Comorbidities. OBM Neurobiol.2022; 6 (2): 1-30. https://doi.org/10.21926/obm.neurobiol.2202120

Reddy N, Doyle M, Hanagandi P, Taranath A, Dahmoush H, Krishnan P, et.al. Neuroradiological mimics of periventricular leukomalacia. J Child Neurol. 2022; 37(2): 151-167. https://doi.org/10.1177/08830738211026052

Khurana R, Shyamsundar K, Taank P, Singh A. Periventricular leukomalacia: an ophthalmic perspective. Med J Armed Forces India. 2021; 77(2): 147–153. https://doi.org/10.1016/j.mjafi.2020.05.013

Paul S, Nahar A, Bhagawati M, Kunwar AJ. A Review on Recent Advances of Cerebral Palsy. Oxid Med Cell Longev. 2022;2022:.2622310. https://doi.org/10.1155/2022/2622310

Moretto E, Murru L, Martano G, Sassone J, Passafaro M. Glutamatergic synapses in neurodevelopmental disorders.Prog Neuro-Psycho pharm. Biol Psychiatry. 2018; 84: 328 342.https://doi.org/10.1016/j.pnpbp.2017.09.014

Hanna H, Youness ER, Orban HAA, El-Bassyouni HT. BDNF as a potential predictive biomarker for patients with pediatric cerebral palsy. F1000 Res. 2022; 11: 1347.https://doi.org/10.12688/f1000research.127917.1.

Bossi S, Dhanasobhon D, Ellis-Davies GCR, Frontera J, de Brito Van Velze M, Lourenço J, et.al. GluN3A excitatory glycine receptors control adult cortical and amygdalar circuits. Neuron. 2022; 110(15): 2438–2454. https://doi.org/10.1016/j.neuron.2022.05.016

Abd Elmagid DS, Magdy H. Evaluation of risk factors for cerebral palsy. Egypt J Neurol Psychiatr Neurosurg. 2021; 57: 1-9. https://doi.org/10.1186/s41983-020-00265-1

Faradila F, Yuliarni S, Rika S, Nur I. Liputo. The Effect of Combination Ovariectomy and D-galactose Administration on Alzheimer’s Animal Model. Baghdad Sci J. 2022; 19(5):1021. http://dx.doi.org/10.21123/bsj.2022.5486

Ahmadi SAY, Beigi Boroujeni M, Pajouhi N, Hasanvand A, Hasanvand A, Jamei SB, et al. Effect of Testosterone Enanthate Modeling of Polycystic Ovary on Liver Irs-2 mRNA Expression in Rats: A Brief Report. Baghdad Sci J. 2021; 18(3): 0480. https://doi.org/10.21123/bsj.2021.18.3.0480

Kakooza-Mwesige A, Andrews C, Peterson S, Mangen FW, Eliasson AC, Forssberg H. Prevalence of cerebral palsy in Uganda: a population-based study. Lancet Glob Health. 2017; 5: 1275–82. https://doi.org/10.1016/S2214-109X(17)30374-1

Woods L, Perez-Garcia V, Hemberger M. Regulation of placental development and its impact on fetal growth—new insights from mouse models. Front endocrinol. 2018; 9: 570.https://doi.org/10.3389/fendo.2018.00570

Chaokromthong K, Sintao N. Sample size estimation using Yamane and Cochran and Krejcie and Morgan and green formulas and Cohen statistical power analysis by G* Power and comparisions. APHEIT International Journal. 2021; 10(2): 76-86.

Arifin WN, Zahiruddin WM. Sample size calculation in animal studies using resource equation approach. The Malays J Med Sci. 2017; 24(5): 101-105.https://doi.org/10.21315/mjms2017.24.5.11

Bernard D. Animal models of cerebral palsy. Dev Med Child Neurol. 2020; 6 (1): 4-4. https://doi.org/10.1111/dmcn.14397

Liu L, Fang L, Duan B, Wang Y, Cui Z, Yang L, et al. Multi-Hit White Matter Injury-Induced Cerebral Palsy Model Established by Perinatal Lipopolysaccharide Injection. Front Pediatr. 2022; 10: 867410. https://doi.org/10.3389/fped.2022.867410

Skrzypczak-Wiercioch A, Sałat K. Lipopolysaccharide-Induced Model of Neuroinflammation: Mechanisms of Action, Research Application and Future Directions for Its Use. Molecules (Basel, Switzerland). 2022; 7(17): 5481. https://doi.org/10.3390/molecules27175481

Shrestha S, Singh M, Mishra SP. The Effect of Piracetam on Valproic Acid Induced Congenital Malformations in Swiss Albino Mice. Nepal Med Coll J. 2019; 21(3): 204-209. https://doi.org/10.3126/nmcj.v21i3.26459

Zhao J, Bi W, Xiao S, Lan X, Cheng X, Zhang J, et al. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci Rep. 2019; 9: 5790. https://doi.org/10.1038/s41598-019-42286-8

Failla MD, Conley YP, Wagner AK. Brain-Derived Neurotrophic Factor (BDNF) in Traumatic Brain Injury-Related Mortality: Interrelationships between Genetics and Acute Systemic and Central Nervous System BDNF Profiles. Neurorehabil Neural Repair 2016; 30: 83–93. https://doi.org/10.1177/1545968315586465

Gustafsson D, Klang A, Thams S, Rostami E. The role of BDNF in experimental and clinical traumatic brain injury. Int J Mol Sci. 2021; 22(7): 3582. https://doi.org/10.3390/ijms22073582

Ng TK, Coughlan C, Heyn P C, Tagawa A, Carollo J J, Kua E H. Increased plasma brain-derived neurotrophic factor (BDNF) as a potential biomarker for and compensatory mechanism in mild cognitive impairment: a case-control study. Aging. 2021; 13(19): 22666-22689. https://doi.org/10.18632/aging.203598

Hansen SL, Lorentzen J, Pedersen LT, Hendrich FL, Jorsal M, Pingel J. Suboptimal 11nutrition and low physical activity are observed together with reduced plasma brain-derived neurotrophic Factor (BDNF) concentration in children with severe cerebral palsy (CP). Nutrients. 2019; 11(3): 620. https://doi.org/10.3390/nu11030620

Pérez-Otaño I, Larsen R S, Wesseling JF. Emerging roles of GluN3-containing NMDA receptors in the CNS. Nat Rev Neurosci. 2016; 17(10): 623-635. https://doi.org/10.1038/nrn.2016.92